Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million.
Related Posts
European markets head for tepid open; Volkswagen annual profit drops
European markets are heading for a mixed open as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump’s trade policies.
Implemented or not, Trump’s 25% tariff threat is challenging the auto industry
On a sales basis, German automaker Volkswagen is the most exposed to tariff risk, followed by Nissan Motor and Stellantis, S&P Mobility reports.
Stock futures inch lower as Wall Street readies for U.S. presidential election: Live updates
Stock futures slipped in overnight trading Sunday as investors geared up for the highly-anticipated U.S. presidential election.